Stamford’s GeneDX sees jump in stock price as it touts 1st-ever adjusted quarterly profit
GeneDx, a Stamford-based genomic testing firm formerly known as Sema4, saw its stock price jump nearly 40% in early morning trading on Tuesday as the company touted its first-ever adjusted quarterly profit. The company reported adjusted net income of $1. …